1. Akers, W.A.: Risk of unoccluded topical steroids in clinical trials. Arch. Derm. (Chicago) 116, 786 (1980).
2. Akers, W.A.: Topical corticosteroids: Proof of efficacy in skin diseases. In: Kligmann, A.M. and Leyden, J.J., Safety and efficacy of topical drugs and cosmetics, Grume & Stratton New York 1982, p.1.
3. Almeyda, J., Burt, B. W.: Double blind controlled study of treatment of atopic eczema with a preparation of hydrocortisone in a new drug delivery system versus betamethason-17-valerate. Brit. J. Derm. 91, 579 (1974).
4. Altmeyer, P.: Zur Tachyphylaxie von Corticoiden an Normalhaut und im Entzündungsmodell. Arztl. Kosmetol. 7, 134 (1977).
5. Altmeyer, P.: Ein Beitrag zur Histologie der von Corticoidexterna verursachten Hautveränderungen. Hautarzt 28, 83 (1977 b).